Pharmafile Logo
Pharmafocus logo
Advanced Search

DMV-Fonterra plans another shake-up for pharma lactose

January 6, 2010
Manufacturing and Production DMV-Fonterra Excipients, FrieslandCampina Domo, lactose

DMV-Fonterra Excipients has agreed to buy the product range of FrieslandCampina Domo for 52.5 million euros in a deal that …

News

Alcon directors protest Novartis takeover bid

January 6, 2010
Research and Development, Sales and Marketing Alcon, Novartis

An independent committee of directors of Alcon has expressed its disappointment with the recent takeover bid from Novartis, saying the …

News

Hospira helps Genzyme tackle manufacturing problems

January 6, 2010
Manufacturing and Production Cerezyme, Fabrazyme, Genzyme, Hospira

Genzyme has taken the decision to move the fill and finish stages of its manufacturing process to Hospira in order …

News
Andrew-Dillon

NICE chief executive knighted in New Year’s honours

January 6, 2010
Andrew Dillon, NHS, NICE, UK, appointment

Andrew Dillon, chief executive of the National Institute for Health and Clinical Excellence (NICE), has been knighted in the 2010 …

Appointment
JGerberding_cdc_photo

Dr Julie Gerberding appointed to head up Merck Vaccines

January 6, 2010
Research and Development, Sales and Marketing Merck, appoinment, research and development, sales and marketing, vaccines

Merck & Co has put a US public health and infectious diseases expert in charge of its $5 billion global …

Appointment
Synovate steve lowery 1

Steve Lowery joins Synovate

January 6, 2010
Sales and Marketing appointment, sales and marketing, synovate

Marketing intelligence agency Synovate has appointed Steve Lowery group head, custom healthcare, in the UK. Lowery joins Synovate from Kantar …

Appointment
Witty

GSK’s Andrew Witty appointed president of EFPIA

January 5, 2010
Research and Development, Sales and Marketing Andrew Witty, EFPIA, GSK, appointment, research and development, sales and marketing

GlaxoSmithKline chief executive Andrew Witty has been appointed president of EFPIA.He previously served as vice-president of the European industry association for two years and takes …

Appointment

Novartis to acquire majority stake in Alcon

January 5, 2010
Sales and Marketing Alcon, Novartis, eye care

Novartis plans to gain a majority hold of global eye care leader Alcon, significantly boosting its presence in the sector. …

News

Sanofi bags consumer healthcare specialist Chattem

January 5, 2010
Chattem, OTC, Sanofi

Sanofi-Aventis looks set to become much bigger in over-the-counter pharmaceuticals with a $1.9 billion agreement to buy US company Chattem. …

News

Strong growth predicted for pharma contract services

January 5, 2010
Manufacturing and Production, Research and Development contract research, industry, manufacturing and production

The market for contract services in the pharmaceutical sector has been pegged back since the end of 2008, but looks …

News

Lilly extends remit for finance chief Derica Rice

January 5, 2010
Sales and Marketing appointment, lilly, sales and marketing

Lilly’s senior vice president and chief financial officer Derica Rice has taken on an expanded role. He becomes executive vice …

Appointment
Roche's new Building 1

Roche plans striking new Basel offices

January 4, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Basel, Roche, construction

Roche has unveiled plans for its new main office building in Basel, Switzerland, that will accommodate more than 1,800 people …

News

Serge Weinberg joins board at Sanofi-Aventis

January 4, 2010
Research and Development, Sales and Marketing Sanofi-Aventis, appointment, research and development, sales and marketing

Serge Weinberg has joined the board of directors at Sanofi-Aventis, replacing Gunter Thielen, who has resigned for personal reasons. The …

Appointment

Medea wins European sedative account

January 4, 2010
Medical Communications Medea, orion, sedative

Medical communications agency Medea Communications has landed a brief to prepare the ground for a new sedative from Finnish company …

News

Cancer Research UK and Merck KGaA to co-develop leukaemia candidate

January 4, 2010
Research and Development Merck Serono, leukaemia, oncology

Cancer Research UK and Cancer Research Technology (CRT), the charity’s development and commercialisation arm, are to undertake a phase I …

News
lung cancer

New approaches in lung cancer

January 1, 2010
Sales and Marketing lung cancer

Lung cancer is the most common cancer in the world, with 1.3 million new cases diagnosed every year. The vast …

Feature

Celgene

January 1, 2010
Research and Development, Sales and Marketing Abraxane, Celgene, Revlimid, Thalidomide

Founded in 1986, Celgene was created as a spin off from the Celanese Corporation. Two years later, the company received …

Feature
The European Medicines Agency concedes greater engagement is needed

Patient involvement must improve, says European regulator

December 31, 2009
Sales and Marketing EMEA, patients

The European Medicines Agency (EMEA) has admitted that the level of patient involvement in its activities is unsatisfactory.As a result …

News

Rebecca Lim to head up WorldEvents’ Asian expansion

December 24, 2009
Business Services Rebecca Lim, WorldEvents, appointment, business services

Rebecca Lim has been appointed by WorldEvents to lead its new Hong Kong office. She is an event professional with …

Appointment

Promising new drugs could bypass UK approval process

December 23, 2009
Sales and Marketing MHRA, MISG, hta, market access

UK patients could next year be given access to drugs that are still in the later stages of clinical development, …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025